ZP
ELDN icon

Zimmer Partners’s Eledon Pharmaceuticals ELDN Stock Holding History

Zimmer Partners’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.29M Sell
1,596,599
-278,401
-15% -$1.01M 0.14% 91
2026
Q1 		$5.78M Sell
1,875,000
-509,228
-21% -$1.2M 0.14% 94
2025
Q4 		$3.6M Buy
2,384,228
+559,228
+31% +$1.33M 0.09% 88
2025
Q3 		$4.73M Buy
1,825,000
+844,318
+86% +$2.47M 0.1% 103
2025
Q2 		$2.66M Buy
980,682
+225,712
+30% +$677K 0.06% 128
2025
Q1 		$2.56M Buy
754,970
+4,970
+0.7% +$20.5K 0.05% 143
2024
Q4 		$3.09M Sell
750,000
-684,727
-48% -$2.7M 0.05% 120
2024
Q3 		$3.57M Sell
1,434,727
-674,977
-32% -$1.81M 0.07% 114
2024
Q2 		$5.57M Buy
+2,109,704
New +$5.04M 0.1% 103

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Zimmer Partners's ELDN Position: Q2 2026 in Review

Zimmer Partners reduced its Eledon Pharmaceuticals (ELDN) stake by 15% in Q2 2026, selling an estimated $1.01M and leaving 1,596,599 shares worth $6.29M. The position accounts for 0.14% of the portfolio, ranked #91.

Zimmer Partners first reported a position in ELDN in Q2 2024 and has held it in 9 quarters since. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Zimmer Partners held 1,596,599 shares of Eledon Pharmaceuticals worth $6.29M as of Q2 2026.
  • Zimmer Partners sold 278,401 Eledon Pharmaceuticals shares in Q2 2026, an estimated $1.01M.
  • Eledon Pharmaceuticals made up 0.14% of Zimmer Partners's portfolio in Q2 2026, its #91 holding.
  • Zimmer Partners first reported a position in Eledon Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Zimmer Partners's 13F filing for Q2 2026, filed 14 Aug 2026.